Last reviewed · How we verify

Venitol Tab. — Competitive Intelligence Brief

Venitol Tab. (Venitol Tab.) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Venotropic agent. Area: Cardiovascular.

marketed Venotropic agent Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Venitol Tab. (Venitol Tab.) — Hanlim Pharm. Co., Ltd.. Venitol is a venotropic agent that improves venous tone and microcirculation by enhancing vascular endothelial function.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Venitol Tab. TARGET Venitol Tab. Hanlim Pharm. Co., Ltd. marketed Venotropic agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Venotropic agent class)

  1. Hanlim Pharm. Co., Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Venitol Tab. — Competitive Intelligence Brief. https://druglandscape.com/ci/venitol-tab. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: